Abstract
The appropriate management of fluid and electrolyte disturbances has led to a dramatic decrease of acute mortality in childhood hemolytic uremic syndrome (H U S). The value of additional anticoagulant therapy therefore has been seriously question. ed but whether or not anticoagulants are useful especially with regard to the long-term evolution of kidney function in the surviving patients has not been established. We have approached this problem by a prospective at random study which started in June 1976 and is still in progress now. Thirty-nine patients have entered the study so far.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Proesmans, W., Binda Ki Muaka, P., Van Damme, B., Vermylen, J., Vlietinck, R., Eeckels, R. (1981). Anticoagulant Versus No Specific Treatment in Childhood Hemolytic Uremic Syndrome. A Randomized Prospective Study. In: Gruskin, A.B., Norman, M.E. (eds) Pediatric Nephrology. Developments in Nephrology, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8319-9_22
Download citation
DOI: https://doi.org/10.1007/978-94-009-8319-9_22
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8321-2
Online ISBN: 978-94-009-8319-9
eBook Packages: Springer Book Archive